Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation
调节内皮细胞免疫代谢和线粒体形态对器官移植的影响
基本信息
- 批准号:10634543
- 负责人:
- 金额:$ 39.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-12 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAlloantigenAllograft ToleranceAllograftingAntigen PresentationAntigen-Presenting CellsAntiinflammatory EffectBlood VesselsBrain DeathCell CommunicationCell LineCellsCessation of lifeChronicCryopreservationDataDoseEndothelial CellsEndotheliumEnvironmentEventFunctional disorderGoalsGraft RejectionGraft SurvivalHeart TransplantationHeterogeneityImaging TechniquesImmuneImmunityImmunologicsImmunosuppressionIn VitroInfectionInfiltrationInflammatoryInjuryIschemiaLaboratoriesLinkLongevityMainstreamingMaintenanceMalignant NeoplasmsMediatingMetabolicMetabolismMitochondriaModelingMorphologyMusOrganOrgan PreservationOrgan ProcurementsOrgan TransplantationOrgan failurePathologyPatientsPeptidesPharmaceutical PreparationsPhasePhenotypePlayProcessRegimenReperfusion InjuryReperfusion TherapyRoleSeveritiesShapesSolidStressT memory cellT-Cell ActivationT-LymphocyteTherapeuticTherapeutic immunosuppressionTimeTransplantationTubular formationVascular DiseasesVertebral columnallograft rejectionclinical translationclinically relevantcurative treatmentscytokineeffector T cellend-stage organ failureexperimental studyfunctional outcomesgraft dysfunctiongraft failureimmune functionimmunogenicimmunogenicityimmunological synapseimplantationimprovedimproved outcomein vivoin vivo Modelinhibitorischemic injurymetabolic profilenatural hypothermianovelnovel strategiesnovel therapeutic interventionpost-transplantpreconditioningpreservationprogramspromoterresponseside effectsmall moleculestandard of carestressorsynaptic functiontransplant model
项目摘要
ABSTRACT: Organ transplantation is a mainstream therapy for patients with organ failure; however, despite
major advances in the field, there has been little progress regarding two major components of transplantation --
organ preservation and maintenance immunosuppression. Although essential, immunosuppressive therapy
carries a significant side-effect burden, often leading to patient death and graft failure. In addition, the process
of organ procurement most often includes use of grafts from brain dead donors followed by hypothermic
preservation of the organs in storage solutions. During these events, the endothelial cells (EC) in the organ
allografts are primed immunologically and are then subjected to the insults of reperfusion. This early injury
predisposes the EC to inappropriate antigen presentation and effects of chronic graft dysfunction, including graft
vasculopathy leading to long-term graft failure. Hypothermic preservation changes the metabolism of the
allograft, which in turn is hypothesized to alter the immunogenicity of the ECs ultimately affecting cellular
functional outcomes. Central to this cascade is the role of the mitochondria in shaping the immunometabolic
milieu of the allograft in the face of cold ischemia and reperfusion injury. In this proposal we, for the first time,
explore the mechanistic relationship between the mitochondrial morphology and immunometabolism of
ECs and their immunogenicity in the setting of transplantation. We build upon our own data to assess the
effects of forcing mitochondrial ultrastructural changes on the immunogenic profile of EC during the preservation
phase of transplantation. We propose that by dampening the early immunogenic effects of ECs, we can create
the opportunity to induce allograft tolerance with the use of reduced immunosuppressive regimens thereby
reducing the deleterious consequences of these necessary drugs. We will employ the scientific premise of
reprograming ECs to a more tolerogenic state by altering their metabolic core such that their ability to induce
proinflammatory changes from alloreactive T cells are diminished. Using clinically relevant in vivo models of
transplantation, we anticipate that altering EC mitochondria will improve graft survival and abrogate the pathology
associated with allograft rejection. Using our preliminary data as a backbone we hypothesize that cold ischemia
exacerbates the immunogenic capacity and metabolic profile of EC by altering mitochondrial morphology
resulting in allograft injury. Additionally, with the following aims, our goal will be to protect organ allografts and
skew the EC to a more tolerogenic phenotype.
Aim 1. We will determine the impact of mitochondrial morphology during organ preservation on
the immunogenicity of endothelial cells in vitro.
Aim 2. We aim to assess the impact of mitochondrial morphology on ischemia reperfusion injury
and acute transplant rejection in vivo.
Pre-treatment with mitochondrial fusion therapeutics will shift the current standard of care in transplantation.
摘要:器官移植是器官衰竭患者的主流治疗方法。然而,尽管
尽管该领域取得了重大进展,但移植的两个主要组成部分却进展甚微——
器官保存和维持免疫抑制。免疫抑制治疗虽然必不可少
具有显着的副作用负担,常常导致患者死亡和移植失败。此外,该过程
器官获取最常包括使用脑死亡捐献者的移植物,然后是低温
在储存溶液中保存器官。在这些事件期间,器官中的内皮细胞 (EC)
同种异体移植物经过免疫学引发,然后遭受再灌注的损害。这早期受伤
使 EC 容易出现不适当的抗原呈递和慢性移植物功能障碍的影响,包括移植物
血管病变导致长期移植失败。低温保存改变了新陈代谢
同种异体移植,假设这反过来会改变 EC 的免疫原性,最终影响细胞
功能结果。该级联的核心是线粒体在塑造免疫代谢中的作用
同种异体移植物面临冷缺血和再灌注损伤的环境。在这项提案中,我们第一次,
探讨线粒体形态与免疫代谢之间的机制关系
EC 及其在移植环境中的免疫原性。我们根据自己的数据来评估
保存过程中强迫线粒体超微结构变化对 EC 免疫原性的影响
移植阶段。我们建议,通过抑制 EC 的早期免疫原性作用,我们可以创造
有机会通过减少免疫抑制方案来诱导同种异体移植耐受
减少这些必要药物的有害后果。我们将采用科学前提
通过改变 ECs 的代谢核心,将其重新编程至更耐受的状态,从而使其能够诱导
同种异体反应性 T 细胞的促炎性变化减少。使用临床相关的体内模型
移植后,我们预计改变 EC 线粒体将提高移植物存活率并消除病理学
与同种异体移植排斥有关。使用我们的初步数据作为支柱,我们假设冷缺血
通过改变线粒体形态来增强 EC 的免疫原性能力和代谢特征
导致同种异体移植物损伤。此外,为了实现以下目标,我们的目标是保护器官同种异体移植物和
使 EC 偏向于更耐受的表型。
目标 1. 我们将确定器官保存过程中线粒体形态对
内皮细胞的体外免疫原性。
目标 2. 我们旨在评估线粒体形态对缺血再灌注损伤的影响
和体内急性移植排斥反应。
线粒体融合疗法的预处理将改变当前移植的护理标准。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Connexins in endothelial cells as a therapeutic target for solid organ transplantation.
内皮细胞中的连接蛋白作为实体器官移植的治疗靶点。
- DOI:
- 发表时间:2022-11
- 期刊:
- 影响因子:0
- 作者:Jaishankar, Dinesh;Quinn, Kristen M;Sanders, Jes;Plumblee, Leah;Morinelli, Thomas A;Nadig, Satish N
- 通讯作者:Nadig, Satish N
Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation.
器官移植中调节性免疫细胞的过继转移。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Oberholtzer, Nathaniel;Atkinson, Carl;Nadig, Satish N
- 通讯作者:Nadig, Satish N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATISH N NADIG其他文献
SATISH N NADIG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATISH N NADIG', 18)}}的其他基金
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)
芝加哥生物医学联盟创业与科学创新技术中心 (CBC - HITES)
- 批准号:
10783500 - 财政年份:2023
- 资助金额:
$ 39.79万 - 项目类别:
Ex vivo maintenance of endothelial cell barrier integrity via gap junction modification to prevent early ischemic injury in solid organ transplantation
通过间隙连接修饰离体维持内皮细胞屏障完整性以预防实体器官移植中的早期缺血性损伤
- 批准号:
10741452 - 财政年份:2023
- 资助金额:
$ 39.79万 - 项目类别:
Modulating endothelial cell immunometabolism and mitochondrial morphology- implications for organ transplantation
调节内皮细胞免疫代谢和线粒体形态——对器官移植的影响
- 批准号:
10170230 - 财政年份:2019
- 资助金额:
$ 39.79万 - 项目类别:
Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation
调节内皮细胞免疫代谢和线粒体形态对器官移植的影响
- 批准号:
10402861 - 财政年份:2019
- 资助金额:
$ 39.79万 - 项目类别:
Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation
调节内皮细胞免疫代谢和线粒体形态对器官移植的影响
- 批准号:
10507521 - 财政年份:2019
- 资助金额:
$ 39.79万 - 项目类别:
Nanoparticle Therapy for Targeted Drug Delivery in Organ Transplantation
器官移植中靶向药物输送的纳米颗粒疗法
- 批准号:
9225201 - 财政年份:2016
- 资助金额:
$ 39.79万 - 项目类别:
相似国自然基金
基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
- 批准号:82304988
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
- 批准号:82305416
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
- 批准号:82374307
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
- 批准号:52371327
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
- 批准号:72302155
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
慢性移植物抗宿主病的机制和治疗
- 批准号:
10493794 - 财政年份:2022
- 资助金额:
$ 39.79万 - 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
- 批准号:
10534556 - 财政年份:2022
- 资助金额:
$ 39.79万 - 项目类别:
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
慢性移植物抗宿主病的机制和治疗
- 批准号:
10698155 - 财政年份:2022
- 资助金额:
$ 39.79万 - 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
- 批准号:
10744193 - 财政年份:2022
- 资助金额:
$ 39.79万 - 项目类别: